PTC Therapeutics, Inc. (PTCT)
70.66
+0.76
(+1.09%)
USD |
NASDAQ |
Feb 20, 16:00
70.59
-0.07
(-0.10%)
After-Hours: 20:00
PTC Therapeutics Profit Margin (Quarterly) : -81.96% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | -3.91% |
| Sarepta Therapeutics, Inc. | -45.06% |
| Ardelyx, Inc. | -0.32% |
| Spyre Therapeutics, Inc. | -- |
| Ovid Therapeutics, Inc. | -9.21K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 27.17% |
| Return on Invested Capital | 2.74K% |
| Gross Profit Margin (Quarterly) | 90.10% |
| Operating Margin (Quarterly) | -49.57% |
| Return on Net Operating Assets | 100.3% |